封面
市場調查報告書
商品編碼
1621380

智慧胰島素筆市場:按類型、可用​​性、應用和最終用戶分類 - 2025-2030 年全球預測

Smart Insulin Pen Market by Type (First Generation Pens, Second Generation Pens), Usability (Prefilled, Reusable), Application, End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年智慧胰島素筆市值為1.4962億美元,預計到2024年將達到1.6995億美元,複合年成長率為14.14%,到2030年將達到3.7764億美元。

智慧胰島素筆是一種先進的醫療設備,旨在透過將傳統胰島素注射與智慧技術相結合,幫助糖尿病患者更有效地管理胰島素注射。這些筆與行動應用程式整合,可以追蹤和記錄胰島素劑量、提供提醒,有時還可以根據個人血糖濃度和趨勢提供個人化的胰島素建議。對智慧胰島素筆的需求源於全球糖尿病盛行率的不斷上升以及對更方便、準確和方便用戶使用的糖尿病管理解決方案的需求。它的用途擴展到需要每日注射胰島素的 1 型和 2 型糖尿病患者。由於強調以患者為中心且具有成本效益的糖尿病管理,這些設備的最終用途主要涵蓋醫院、診所和家庭醫療保健。

主要市場統計
基準年[2023] 1.4962億美元
預測年份 [2024] 16995萬美元
預測年份 [2030] 37764萬美元
複合年成長率(%) 14.14%

從成長要素來看,糖尿病盛行率上升、健康意識增強以及數位健康創新的推動是市場的主要驅動力。此外,醫療保健領域智慧技術和分析的不斷增強正在推動這些筆的採用。隨著與其他糖尿病護理系統整合的需求不斷成長以及對更個人化的醫療保健解決方案的推動,新的商機正在出現。然而,挑戰依然存在,包括高成本、新興地區知名度低以及阻礙市場擴張的監管障礙。有關這些設備收集的資料的隱私問題也是一個限制因素。

創新和研究應著重於改善設備連接性、增強用戶介面設計以更好地與患者互動,以及擴大與更廣泛的胰島素和糖尿病管理應用程式的兼容性。此外,與內分泌學家和醫療保健提供者建立夥伴關係關係可以促進更好的接受和融入護理常規。在技​​術進步和患者對方便、準確的糖尿病管理解決方案日益成長的需求的推動下,市場本質上是動態的。

市場動態:揭示快速發展的智慧胰島素筆市場的關鍵市場洞察

供需的動態交互作用正在改變智慧胰島素筆市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 全球糖尿病患者數量不斷增加
    • 強調個人化劑量計算與血糖監測
    • 家庭醫療保健環境中糖尿病護理連網型設備和應用程式的接受度不斷提高
  • 市場限制因素
    • 智慧胰島素筆高成本
  • 市場機會
    • 透過創新開發改善產品供應
    • 政府對家庭醫療保健解決方案的支持和投資
  • 市場挑戰
    • 處理智慧胰島素筆的意識有限和技術問題

波特五力:駕馭智慧胰島素筆市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰,以確保更強大的市場地位。

PESTLE分析:了解智慧胰島素筆市場的外部影響

外部宏觀環境因素對智慧胰島素筆市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解智慧胰島素筆市場的競爭格局

對智慧胰島素筆市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣智慧胰島素筆市場供應商績效評估

FPNV定位矩陣是評估智慧胰島素筆市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製智慧胰島素筆市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,對智慧胰島素筆市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開發:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、未開發地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 世界各地的糖尿病患者不斷增加
      • 專注於個別劑量計算和血糖值監測
      • 家庭醫療保健環境中用於糖尿病護理的連網設備和應用程式將變得更加流行
    • 抑制因素
      • 智慧胰島素筆高成本
    • 機會
      • 透過創新開發完善產品陣容
      • 對家庭醫療保健解決方案的支持性政府措施和投資
    • 任務
      • 處理智慧胰島素筆的意識低和技術問題
  • 市場區隔分析
    • 類型:第二代筆讓您更能控制糖尿病管理
    • 易於使用:可重複使用的智慧胰島素筆具有成本效益
    • 應用:增加智慧型胰島素筆的使用,克服第二型糖尿病負擔
    • 最終用戶:智慧胰島素筆在家庭醫療保健環境中的使用正在迅速增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章智慧胰島素筆市場:按類型

  • 第一代筆
  • 第二代筆
    • 藍牙相容
    • USB連接

第7章智慧型胰島素筆市場:依可用性

  • 預先填充
  • 可重複使用的

第8章智慧型胰島素筆市場:依應用分類

  • 1型糖尿病
  • 2型糖尿病

第 9 章 智慧胰島素筆市場:依最終用戶分類

  • 門診手術中心
  • 家庭護理設置
  • 醫院/診所

第10章 美洲智慧胰島素筆市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太智慧胰島素筆市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲智慧胰島素筆市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭場景分析
    • 雅培收購帽子製造商 Bigfoot
    • FDA核准BioCorp 的 Mallya 智慧胰島素筆設備
    • BIOCORP 和 NOVO NORDISK 就 Mallya 智慧感測器達成新協議,加強夥伴關係
  • 戰略分析和建議

公司名單

  • B. Braun SE
  • Becton, Dickinson and Company
  • Berlin-Chemie AG
  • Bigfoot Biomedical Inc.
  • BIOCORP Production
  • Dexcom, Inc.
  • Diamesco Co., Ltd.
  • Eli Lilly and Company
  • Emperra GmbH
  • F. Hoffmann-La Roche AG
  • HTL-Strefa, Inc.
  • Insulet Corporation
  • IQVIA Inc.
  • Jiangsu Deflu Medical Device Co. Ltd.
  • Medtronic PLC
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • pendiq GmbH
  • Sanofi SA
  • Tandem Diabetes Care Inc.
  • Ypsomed Holding AG
Product Code: MRR-0375F3EA9C4E

The Smart Insulin Pen Market was valued at USD 149.62 million in 2023, expected to reach USD 169.95 million in 2024, and is projected to grow at a CAGR of 14.14%, to USD 377.64 million by 2030.

Smart insulin pens are advanced medical devices designed to aid individuals with diabetes in managing their insulin delivery more effectively by combining traditional insulin injection with smart technology. These pens integrate with mobile applications to track and record insulin doses, provide reminders, and sometimes offer personalized insulin recommendations based on individual glucose levels and trends. The necessity for smart insulin pens arises from the increasing incidence of diabetes worldwide and the demand for more convenient, precise, and user-friendly diabetes management solutions. Their application extends to both Type 1 and Type 2 diabetes patients who require daily insulin administration. The end-use of these devices predominantly spans hospitals, clinics, and home healthcare settings, given the emphasis on patient-centric and cost-effective diabetes management.

KEY MARKET STATISTICS
Base Year [2023] USD 149.62 million
Estimated Year [2024] USD 169.95 million
Forecast Year [2030] USD 377.64 million
CAGR (%) 14.14%

In terms of growth factors, the rise in diabetes prevalence, escalating health awareness, and the push towards digital health innovations significantly drive the market. Moreover, the continual enhancement of smart technologies and analytics in healthcare promotes the adoption of these pens. New opportunities are emerging due to the growing demand for integration with other diabetes care systems and the push for more personalized healthcare solutions. However, challenges persist, such as high costs, limited awareness in emerging regions, and regulatory hurdles that can impede market expansion. Privacy concerns regarding data collected by these devices also pose a limitation.

Innovation and research should focus on improving device connectivity, enhancing user interface designs for better patient engagement, and expanding compatibility with a broader range of insulin types and diabetes management apps. Additionally, targeting partnerships with endocrinologists and healthcare providers can facilitate better acceptance and integration into care routines. The market is inherently dynamic, driven by technological advancements and increasing patient demand for convenient and precise diabetes management solutions, suggesting a high potential for growth and evolution in smart insulin pen offerings.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Insulin Pen Market

The Smart Insulin Pen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in diabetes patients worldwide
    • Emphasis on calculating personalized doses and glucose monitoring
    • Rising acceptance of connected devices and apps for diabetes care in home healthcare settings
  • Market Restraints
    • High costs of smart insulin pens
  • Market Opportunities
    • Improvements in product offerings with innovative developments
    • Supportive government initiatives and investments for home healthcare solutions
  • Market Challenges
    • Limited awareness and technical issues associated with handling smart insulin pens

Porter's Five Forces: A Strategic Tool for Navigating the Smart Insulin Pen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Insulin Pen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Insulin Pen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Insulin Pen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Insulin Pen Market

A detailed market share analysis in the Smart Insulin Pen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Insulin Pen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Insulin Pen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Insulin Pen Market

A strategic analysis of the Smart Insulin Pen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Insulin Pen Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson and Company, Berlin-Chemie AG, Bigfoot Biomedical Inc., BIOCORP Production, Dexcom, Inc., Diamesco Co., Ltd., Eli Lilly and Company, Emperra GmbH, F. Hoffmann-La Roche AG, HTL-Strefa, Inc., Insulet Corporation, IQVIA Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk A/S, Owen Mumford Ltd., pendiq GmbH, Sanofi S.A., Tandem Diabetes Care Inc., and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Smart Insulin Pen Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across First Generation Pens and Second Generation Pens. The Second Generation Pens is further studied across Bluetooth-Enabled and USB Connected.
  • Based on Usability, market is studied across Prefilled and Reusable.
  • Based on Application, market is studied across Type I Diabetes and Type II Diabetes.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Home Care Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in diabetes patients worldwide
      • 5.1.1.2. Emphasis on calculating personalized doses and glucose monitoring
      • 5.1.1.3. Rising acceptance of connected devices and apps for diabetes care in home healthcare settings
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of smart insulin pens
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in product offerings with innovative developments
      • 5.1.3.2. Supportive government initiatives and investments for home healthcare solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Limited awareness and technical issues associated with handling smart insulin pens
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Second-generation pens offer higher control to diabetes management
    • 5.2.2. Usability: Adoption of reusable smart insulin pens due to its cost-efficiency
    • 5.2.3. Application: Increasing use of smart insulin pens to overcome the burden of Type II diabetes
    • 5.2.4. End-User: Proliferating usage of smart insulin pens in home healthcare settings
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Insulin Pen Market, by Type

  • 6.1. Introduction
  • 6.2. First Generation Pens
  • 6.3. Second Generation Pens
    • 6.3.1. Bluetooth-Enabled
    • 6.3.2. USB Connected

7. Smart Insulin Pen Market, by Usability

  • 7.1. Introduction
  • 7.2. Prefilled
  • 7.3. Reusable

8. Smart Insulin Pen Market, by Application

  • 8.1. Introduction
  • 8.2. Type I Diabetes
  • 8.3. Type II Diabetes

9. Smart Insulin Pen Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Home Care Settings
  • 9.4. Hospitals & Clinics

10. Americas Smart Insulin Pen Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Smart Insulin Pen Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Smart Insulin Pen Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Abbott to Buy Smart Insulin Pen Cap Maker Bigfoot
    • 13.3.2. FDA Clears Mallya Smart Insulin Pen Device from Biocorp
    • 13.3.3. BIOCORP and NOVO NORDISK Strengthen Their Partnership With a New Agreement on Mallya Smart Sensor
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. B. Braun SE
  • 2. Becton, Dickinson and Company
  • 3. Berlin-Chemie AG
  • 4. Bigfoot Biomedical Inc.
  • 5. BIOCORP Production
  • 6. Dexcom, Inc.
  • 7. Diamesco Co., Ltd.
  • 8. Eli Lilly and Company
  • 9. Emperra GmbH
  • 10. F. Hoffmann-La Roche AG
  • 11. HTL-Strefa, Inc.
  • 12. Insulet Corporation
  • 13. IQVIA Inc.
  • 14. Jiangsu Deflu Medical Device Co. Ltd.
  • 15. Medtronic PLC
  • 16. Novo Nordisk A/S
  • 17. Owen Mumford Ltd.
  • 18. pendiq GmbH
  • 19. Sanofi S.A.
  • 20. Tandem Diabetes Care Inc.
  • 21. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. SMART INSULIN PEN MARKET RESEARCH PROCESS
  • FIGURE 2. SMART INSULIN PEN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART INSULIN PEN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART INSULIN PEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART INSULIN PEN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART INSULIN PEN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL SMART INSULIN PEN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL SMART INSULIN PEN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. SMART INSULIN PEN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. SMART INSULIN PEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART INSULIN PEN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART INSULIN PEN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART INSULIN PEN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART INSULIN PEN MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART INSULIN PEN MARKET SIZE, BY FIRST GENERATION PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART INSULIN PEN MARKET SIZE, BY BLUETOOTH-ENABLED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART INSULIN PEN MARKET SIZE, BY USB CONNECTED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART INSULIN PEN MARKET SIZE, BY PREFILLED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART INSULIN PEN MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMART INSULIN PEN MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMART INSULIN PEN MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL SMART INSULIN PEN MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL SMART INSULIN PEN MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL SMART INSULIN PEN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES SMART INSULIN PEN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDONESIA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. SOUTH KOREA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. TAIWAN SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. THAILAND SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. VIETNAM SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA SMART INSULIN PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 127. DENMARK SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. EGYPT SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. FINLAND SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. FRANCE SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. GERMANY SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. ISRAEL SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. ITALY SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. NETHERLANDS SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. NIGERIA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. NORWAY SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. POLAND SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. QATAR SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. RUSSIA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. SAUDI ARABIA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. SOUTH AFRICA SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. SPAIN SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. SWEDEN SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWITZERLAND SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. TURKEY SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED ARAB EMIRATES SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED KINGDOM SMART INSULIN PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM SMART INSULIN PEN MARKET SIZE, BY SECOND GENERATION PENS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM SMART INSULIN PEN MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM SMART INSULIN PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM SMART INSULIN PEN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. SMART INSULIN PEN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 233. SMART INSULIN PEN MARKET, FPNV POSITIONING MATRIX, 2023